QUOTE OF THE DAY
QUICKLINKS AND VIEW OPITONS
SUMMARY VIEW
NEW! Page 1 of 1. Go to page
Tuesday, February 23, 2010
AVANDIA
Diabetes drug Avandia increases heart attacks 43%; Glaxo stole manuscript says Dr. Steve Nissen
The diabetes drug Avandia (Rosiglitazone Maleate) increases the risk of heart attack by 43% according to a study by Steven Nissen, MD, Chairman of the Department of Cardiovascular Medicine of the Cleveland Clinic in Cleveland, Ohio.
In an interview on CNBC’s Squawk Box on Feb 22, 2010, Dr. Nissen noted that Glaxo, the maker of Avandia, stole a copy of his manuscript—or as Mike Huckman of CNBC stated, they were given a copy of the manuscript by one of the peer reviewers for the New England Journal of Medicine, who later claimed he wasn’t feeling well, and didn’t know what he was doing.
Dr. Nissen said that after determining that the study was scientifically correct, Glaxo then planned a Public Relations campaign to discredit it.
Read the entire article | Email this article
Thursday, November 18, 2004
Actos (pioglitazone) and Avandia (rosiglitazone) cause significant weight gain in 48-58% of patients
Actos (pioglitazone), an antidiabetic medicine, causes significant weight gain in 48 percent of patients who take it according to a study from Australia. Avandia (rosiglitazone), another antidiabetic medicine, causes significant weight loss in 58 percent of patients.
Read the entire article | Email this article
© Copyright 2003-2009 - Larry Hobbs - All Rights Reserved.